|
MedChemExpress
ac functional group pep rgdfkac Ac Functional Group Pep Rgdfkac, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ac functional group pep rgdfkac/product/MedChemExpress Average 93 stars, based on 1 article reviews
ac functional group pep rgdfkac - by Bioz Stars,
2026-06
93/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
ep td139 group ![]() Ep Td139 Group, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ep td139 group/product/Selleck Chemicals Average 93 stars, based on 1 article reviews
ep td139 group - by Bioz Stars,
2026-06
93/100 stars
|
Buy from Supplier |
|
Dainippon Sumitomo
td-2131 (phenol novolac resin, hydroxyl group equivalent: 104 g/eq) ![]() Td 2131 (Phenol Novolac Resin, Hydroxyl Group Equivalent: 104 G/Eq), supplied by Dainippon Sumitomo, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/td-2131 (phenol novolac resin, hydroxyl group equivalent: 104 g/eq)/product/Dainippon Sumitomo Average 90 stars, based on 1 article reviews
td-2131 (phenol novolac resin, hydroxyl group equivalent: 104 g/eq) - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
Journal: Neuroimmunomodulation
Article Title: Inhibition of Galectin-3 in a Rat Model of Epilepsy and Kainate-Activated BV2 Cells Limits Microglial Activation Through the NLRP3/Pyroptosis Pathway.
doi: 10.1159/000534833
Figure Lengend Snippet: Fig. 4. Inhibition of galectin-3 represses microglial activation in KA-treated microglia. a–f BV2 cells or primary microglia were treated with 100 μM KA for 24 h. For inhibition of galectin-3, BV2 cells or primary microglia were transfected with lentivirus vectors carrying Lgals3 shRNA or treated with 20 μM TD139 for 24 h. a–c The Iba1 expression was analyzed by immunofluorescence. d–f The protein expression of galectin-3 and Iba1 was analyzed by Western blot (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001.
Article Snippet: The EP model was successfully established when the seizure activity reached ≥ grade IV and continued for >30 min. For the
Techniques: Inhibition, Activation Assay, Transfection, shRNA, Expressing, Western Blot
Journal: Neuroimmunomodulation
Article Title: Inhibition of Galectin-3 in a Rat Model of Epilepsy and Kainate-Activated BV2 Cells Limits Microglial Activation Through the NLRP3/Pyroptosis Pathway.
doi: 10.1159/000534833
Figure Lengend Snippet: Fig. 5. Inhibition of galectin-3 represses the activation of NLRP3 inflammasome in KA-treated microglia. a–c BV2 cells or primary microglia were treated with 100 μM KA for 24 h. For inhibition of galectin-3, BV2 cells or primary microglia were transfected with lentivirus vectors carrying Lgals3 shRNA or treated with 20 μM TD139 for 24 h. The expression of NLRP3, ASC, C-caspase-1, and GSDMD-N was analyzed by Western blot (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001.
Article Snippet: The EP model was successfully established when the seizure activity reached ≥ grade IV and continued for >30 min. For the
Techniques: Inhibition, Activation Assay, Transfection, shRNA, Expressing, Western Blot